Immunogenicity of personalized dendritic-cell therapy in HIV-1 infected individuals under suppressive antiretroviral treatment: interim analysis from a phase II clinical trial.
AIDS Res Ther
; 19(1): 2, 2022 01 12.
Article
in En
| MEDLINE
| ID: mdl-35022035
Key words
Full text:
1
Database:
MEDLINE
Main subject:
HIV Infections
/
HIV-1
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
AIDS Res Ther
Year:
2022
Type:
Article
Affiliation country:
Brazil